I completed my undergraduate and postgraduate studies in London, UK at Brunel University, and Barts and London School of Medicine and Dentistry, respectively. I began my postdoctoral position at IOR in 2005. I have been active in the field of lymphoma research since 2009, studying the genetic and epigenetic mechanisms underlying lymphomagenesis and investigating novel anti-lymphoma agents. I have a keen interest in epigenetics and my research therefore has a particular focus on epigenetic agents, their activities and mechanisms of action in lymphomas. The opportunity to work in collaboration with other academic groups and with industry on novel anti-lymphoma agents is a satisfying aspect of my research and I look forward to contributing further to new discoveries in the therapeutic targeting of lymphomas.